Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| S35G2 | Q8TBE7 | Solute carrier family 35 member G2 (Transmembrane protein 22) | Predicted membrane proteinsTransporters | 10 | Fusion and delivery mediation | 1 | 0.50 | |||
| S38A2 | Q96QD8 | Sodium-coupled neutral amino acid symporter 2 (Amino acid transporter A2) (Protein 40-9-1) (Solute carrier family 38 member 2) (System A amino acid transporter 2) (System A transporter 1) (System N amino acid transporter 2) | Essential proteinsFDA approved drug targetsMetabolic proteins | 11 | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| S38A7 | Q9NVC3 | Sodium-coupled neutral amino acid transporter 7 (Solute carrier family 38 member 7) | Predicted membrane proteinsTransporters | 11 | Fusion and delivery mediation | 1 | 0.50 | |||
| S39A2 | Q9NP94 | Zinc transporter ZIP2 (6A1) (Eti-1) (Solute carrier family 39 member 2) (Zrt- and Irt-like protein 2) (ZIP-2) (hZIP2) | Metabolic proteinsPredicted membrane proteinsTransporters | 8 | Fusion and delivery mediation | 1 | 0.50 | |||
| S39AE | Q15043 | Metal cation symporter ZIP14 (LIV-1 subfamily of ZIP zinc transporter 4) (LZT-Hs4) (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14) | Disease related genesHuman disease related genesMetabolic proteins | 6 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | |||
| S40A1 | Q9NP59 | Ferroportin (Ferroportin-1) (Iron-regulated transporter 1) (Solute carrier family 40 member 1) | Disease related genesHuman disease related genesMetabolic proteins | 12 | Acute disease anaemiaAnemiaMyelodysplastic syndrome | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| S46A3 | Q7Z3Q1 | Lysosomal proton-coupled steroid conjugate and bile acid symporter SLC46A3 (Solute carrier family 46 member 3) | Predicted membrane proteinsTransporters | 11 | Fusion and delivery mediation | 1 | 0.50 | |||
| S4A4 | Q9Y6R1 | Electrogenic sodium bicarbonate cotransporter 1 (Sodium bicarbonate cotransporter) (Na(+)/HCO3(-) cotransporter) (Solute carrier family 4 member 4) (kNBC1) | Disease related genesHuman disease related genesMetabolic proteins | 12 | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| SC5A1 | P13866 | Sodium/glucose cotransporter 1 (Na(+)/glucose cotransporter 1) (High affinity sodium-glucose cotransporter) (Solute carrier family 5 member 1) | Disease related genesFDA approved drug targetsHuman disease related genes | 14 | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| SC5A3 | P53794 | Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3) | 12 | Fusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.50 | ||||
| SC5A6 | Q9Y289 | Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (hSMVT) (Solute carrier family 5 member 6) | Disease related genesMetabolic proteinsPlasma proteins | 13 | Substance abuse | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | ||
| SC5AC | Q1EHB4 | Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12) | Metabolic proteinsPredicted membrane proteinsTransporters | 13 | Fusion and delivery mediation | 1 | 0.50 | |||
| SCN1A | P35498 | Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1) | 24 | Fusion and delivery mediation | 1 | 0.50 | ||||
| SCN5A | Q14524 | Sodium channel protein type 5 subunit alpha (Sodium channel protein cardiac muscle subunit alpha) (Sodium channel protein type V subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.5) (hH1) | 24 | Abnormal micturitionAngina pectorisBacterial infection | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| SCN8A | Q9UQD0 | Sodium channel protein type 8 subunit alpha (Sodium channel protein type VIII subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.6) | 24 | Epilepsy/seizureEpileptic encephalopathy | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| SCN9A | Q15858 | Sodium channel protein type 9 subunit alpha (Neuroendocrine sodium channel) (hNE-Na) (Peripheral sodium channel 1) (PN1) (Sodium channel protein type IX subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.7) | Disease related genesFDA approved drug targetsHuman disease related genes | 24 | AsthmaBipolar disorderChronic pain | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| SCNND | P51172 | Epithelial sodium channel subunit delta (Delta-ENaC) (ENaCD) (Epithelial Na(+) channel subunit delta) (Amiloride-sensitive sodium channel subunit delta) (Delta-NaCH) (Nonvoltage-gated sodium channel 1 subunit delta) (SCNED) | FDA approved drug targetsMetabolic proteinsPredicted intracellular proteins | 2 | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| SDC2 | P34741 | Syndecan-2 (SYND2) (Fibroglycan) (Heparan sulfate proteoglycan core protein) (HSPG) (CD antigen CD362) | CD markersPredicted membrane proteins | 1 | Clinical-translation mediationImmune mediationMetabolism mediation | 1 | 0.50 | |||
| SEM4D | Q92854 | Semaphorin-4D (A8) (BB18) (GR3) (CD antigen CD100) | CD markersPlasma proteinsPredicted intracellular proteins | 1 | Choreiform disorderLung cancerMetastatic lymph node neoplasm | Adhesion and uptake mediationClinical-translation mediationReceptor-signaling mediation | 1 | 0.50 | ||
| SERC5 | Q86VE9 | Serine incorporator 5 | Predicted membrane proteinsTransporters | 9 | Fusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| SHSA6 | Q6ZSJ9 | Protein shisa-6 | Predicted membrane proteinsTransporters | 1 | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | |||
| SIA8E | O15466 | Alpha-2,8-sialyltransferase 8E (EC 2.4.99.-) (Sialyltransferase 8E) (SIAT8-E) (Sialyltransferase St8Sia V) (ST8SiaV) | Metabolic proteinsPredicted membrane proteins | 1 | Metabolism mediation | 1 | 0.50 | |||
| SIGL7 | Q9Y286 | Sialic acid-binding Ig-like lectin 7 (Siglec-7) (Adhesion inhibitory receptor molecule 1) (AIRM-1) (CDw328) (D-siglec) (QA79 membrane protein) (p75) (CD antigen CD328) | CD markersPredicted intracellular proteinsPredicted membrane proteins | 1 | Immune mediation | 1 | 0.50 | |||
| SL9A3 | P48764 | Sodium/hydrogen exchanger 3 (Na(+)/H(+) exchanger 3) (NHE-3) (Solute carrier family 9 member 3) | Disease related genesFDA approved drug targetsHuman disease related genes | 13 | Angina pectorisBreathing abnormalityCardiac arrhythmia | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| SL9A4 | Q6AI14 | Sodium/hydrogen exchanger 4 (Na(+)/H(+) exchanger 4) (NHE-4) (Solute carrier family 9 member 4) | Metabolic proteinsPredicted membrane proteinsTransporters | 10 | Fusion and delivery mediation | 1 | 0.50 |